Cystic Fibrosis Newswire (Page 4)

Comprehensive Real-Time News Feed for Cystic Fibrosis. (Page 4)

Results 61 - 80 of 786 in Cystic Fibrosis

  1. Cystic fibrosis: Fear of genetic disease gradually wanes with advances in treatmentRead the original story w/Photo

    Sunday Jun 29 | El Paso Times

    ... child with ten toes, ten fingers and zero medical conditions. At 16 days old, Zoey was diagnosed with cystic fibrosis, or CF, an inherited chronic disease that affects the lungs and digestive system. "Zoey is perfect for me," said Alyssa ...

    Comment?

  2. 40% Pop: Is this Ground Breaking Biotech Still a Buy?Read the original story

    Sunday Jun 29 | The Motley Fool

    With ground breaking cystic fibrosis treatment data, Vertex shares surged 40% in a single day last week.

    Comment?

  3. The Clarksville Great Strides Walk for Cystic Fibrosis is a Huge SuccessRead the original story w/Photo

    Sunday Jun 29 | The Leaf-Chronicle

    The 2014 Clarksville Great Strides Walk for Cystic Fibrosis was held on June 28th at Legends Bank in downtown Clarksville.

    Comment?

  4. Just Breathe Adult PromRead the original story

    Saturday Jun 28 | WTHI-TV Terre Haute

    "The CF foundation receives no federal funding. All of the dollars raised are from donations. And that's why its very important that we raise the funds," said Bonnie Ritchey, a volunteer for Indiana's chapter of the Cystic Fibrosis Foundation.

    Comment?

  5. News of Cure 'Monumental' for Cystic Fibrosis Sufferers - Iowa CFF...Read the original story

    Friday Jun 27 | PRWeb

    ... studies of a combination of two medications have been successful for patients with the most common form of cystic fibrosis is wonderful, says Paul N. Greenwood, president of the Iowa chapter of the Cystic Fibrosis Foundation and CEO of Des ...

    Comment?

  6. NovaBiotics Ltd's Wins Entrepreneur Of The Year At The 2014 Grampian...Read the original story

    Friday Jun 27 | BioSpace

    ... Taro Pharmaceuticals. NovaBiotics is also developing NM001 (LynovexA ), an orphan drug treatment for cystic fibrosis. NM001 has a unique dual antibacterial-mucoactive mode of action that kills bacteria, disables biofilms and disrupts excess mucous ...

    Comment?

  7. Out and About with the Maryland Chapter of the Cystic Fibrosis FoundationRead the original story w/Photo

    Friday Jun 27 | Business Journal

    Maryland Chapter Cystic Fibrosis Foundation board chairman Aris Melissaratos, executive in residence and senior advisor to the dean at Johns Hopkins University Carey School of Business; Cystic Fibrosis Foundation executive director Josie Schaeffer; Spring Swing co-chair Jamie Seymour; Spring Swing co-chair Chas Seymour, general manager and vice ... (more)

    Comment?

  8. Oracle Snags Micros Systems, Vertex Soars & America Exports OilRead the original story w/Photo

    Thursday Jun 26 | TheStreet.com

    ... Meanwhile, shares of Vertex Pharmaceuticals soared more than 40% Tuesday after the drugmaker said its cystic fibrosis treatment worked better than a placebo in a late-stage study. Cystic fibrosis is a rare inherited disease that causes thick mucus ...

    Comment?

  9. Mariners come together for Cystic Fibrosis fundraiserRead the original story w/Photo

    Thursday Jun 26 | Seattle Mariners

    The routine of a Major League Baseball season is grinding and at times monotonous, but it pales in comparison to what those living with cystic fibrosis have to go through every day.

    Comment?

  10. New Therapy Gives Hope to Cystic Fibrosis PatientsRead the original story w/Photo

    Wednesday Jun 25 | Voice of America

    Cystic fibrosis is one of the most common genetic disorders. It compromises a patient's ability to breathe, digest food and ultimately leads to early death among the disease's young patients.

    Comment?

  11. Vertex Announces Drug Combination Improves Lung Capacity Of CF PatientsRead the original story w/Photo

    Thursday Jun 26 | BioResearch Online

    Vertex Pharmaceuticals, which is based out of Boston, has announced that a combination of two drugs made some improvements to the lung capacity of patients with cystic fibrosis.

    Comment?

  12. 11 'ugly stocks' are sitting pretty nowRead the original story w/Photo

    Thursday Jun 26 | USA Today

    ... darlings emerged. The biggest rags-to-riches story in the second quarter was Vertex. After the company's cystic fibrosis treatment breakthrough announced Tuesday, the stock reversed its 4.8% loss in the first quarter and then some. Vertex stock ...

    Comment?

  13. Scientist makes major cystic fibrosis breakthroughRead the original story

    Thursday Jun 26 | PhysOrg Weblog

    A Queen's University doctor has played a key role in a major breakthrough to change the lives of cystic fibrosis sufferers.

    Comment?

  14. INO Cares Campaign Supports Mikey Medium English SchoolRead the original story

    Thursday Jun 26 | PR.com

    ... the beginning of this year, INO.com has sent donations to the South County Assistance Network (SCAN), the Cystic Fibrosis Foundation, the National Multiple Sclerosis Society, the Crohn's & Colitis Foundation of America, Rebuilding Together of Anne ...

    Comment?

  15. Why Valero Energy Corporation, Phillips 66, and Vertex Pharmaceuticals Incorporated Are Today's 3 WoRead the original story

    Wednesday Jun 25 | The Motley Fool

    ... its "TRAFFIC" and "TRANSPORT" trials met the company's goals. Vertex is trying to use a combination of its cystic fibrosis drug, Kalydeco, and another drug, lumacaftor, to gain approval from regulators to market the combo as a treatment that ...

    Comment?

  16. New cystic fibrosis drug lumacaftor shows promiseRead the original story w/Photo

    Wednesday Jun 25 | Examiner.com

    Lumacaftor, an experimental cystic-fibrosis drug, in combination with another CF medication, produced a statistically significant improvement in patients' lung function compared with placebo in two late-stage studies Cystic fibrosis is a life-threatening genetic disease, which primarily affects the lungs and digestive system.

    Comment?

  17. Mad About Missing Vertex Pharma's Big Move? Don't Be, The Stock Is Still UndervaluedRead the original story w/Photo

    Wednesday Jun 25 | TheStreet.com

    BOSTON -- Remember this slide? A little more than one year ago, I wrote a column about this slide , which came from a Vertex Pharmaceuticals presentation at the European Cystic Fibrosis Society meeting.

    Comment?

  18. Trent BlackburnRead the original story

    Jun 23, 2014 | Salem News

    Trent Allen Blackburn, 20, of Willard Road, died at 2:39 a.m. Monday at University Hospital RB &C in Cleveland following a courageous battle with cystic fibrosis.

    Comment?

  19. Upgrading Connectivity: Upgrading Machine Operation in Automation IndustriesRead the original story

    Jun 23, 2014 | Control Design

    The eFlow nebulizer, developed by Pari Pharma in Grafelfing, Germany, has been used to treat cystic fibrosis patients for many years.

    Comment?

  20. Yukon girl's condition improving on new cystic fibrosis drugRead the original story w/Photo

    Jun 23, 2014 | CBC News

    Rueckenbach, 13, has a rare mutation of cystic fibrosis. Kalydeco, the newly-approved drug to treat her condition costs as much as $350,000 a year.

    Comment?